Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.497
https://www.valueinhealthjournal.com/article/S1098-3015(13)00568-8/fulltext
Section Title :
Neurological Disorders
Section Order :
38
First Page :
A105
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00568-8&doi=10.1016/j.jval.2013.03.497